What is the difference between fiduciary liability and D&O insurance for a biotech with employee benefit plans?

D&O insurance covers claims against directors and officers arising from their management decisions — wrongful acts, breach of duty to the company or shareholders, securities claims, regulatory investigations. It does not cover ERISA fiduciary breach claims arising from the administration of employee benefit plans, even when the named defendants are the same directors and officers.

Fiduciary liability insurance covers ERISA breach-of-fiduciary-duty claims — claims that the plan fiduciaries selected imprudent investment options, charged excessive fees, failed to monitor plan performance, breached the duty of loyalty, or otherwise mismanaged a 401(k), health plan, ESOP, or other ERISA-governed benefit plan.

A biotech with 50 employees and a 401(k) plan faces two distinct liability exposures: (1) shareholder or regulator claims against management decisions (covered by D&O), and (2) plan participant claims that the 401(k) fee structure was imprudent or that investment options were poorly selected (covered by fiduciary).

The plaintiff bar has built a substantial practice around ERISA 401(k) fee litigation — even small employers can face class-action claims if the plan structure is alleged to be imprudent. Without fiduciary liability, the named plan fiduciaries (typically the CFO and senior HR leader) face personal exposure that D&O won't respond to.

Fiduciary liability is typically purchased as a standalone $1M-$5M policy or as a sub-limit within a packaged management liability program (D&O + EPLI + fiduciary). For clinical-stage biotechs, $1M-$3M is common; for IPO-bound biotechs with larger plan asset balances, $5M+ is typical.

The premium is modest — typically $2,000-$8,000 annually for clinical-stage biotech depending on plan asset size and number of participants. Cost scales with plan asset balance.

Fiduciary liability is fiduciary-claim coverage — it does not cover the underlying benefit obligations of the plan (those are the plan's liability, not the fiduciary's). It does not cover ERISA Section 502(l) penalties, criminal fines, or intentionally fraudulent breaches.

It does not cover claims that the company itself owes the participants (those are the company's contractual obligations, not fiduciary breach claims). It does not cover claims arising from non-ERISA benefit plans (cafeteria plans without ERISA coverage, certain top-hat plans).

The threshold is typically when the company sponsors any ERISA-governed plan — a 401(k), self-funded health plan, certain top-hat deferred comp plans, an ESOP. The premium is small enough that most biotechs with 25+ employees and a 401(k) carry $1M-$3M fiduciary as standard. Some D&O carriers will include fiduciary as a $250K-$1M sub-limit without separate underwriting; for plans with >$5M in assets, a standalone limit is typically appropriate.